Chuanshu Huang

18.3k total citations · 1 hit paper
301 papers, 13.0k citations indexed

About

Chuanshu Huang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chuanshu Huang has authored 301 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 213 papers in Molecular Biology, 82 papers in Oncology and 81 papers in Cancer Research. Recurrent topics in Chuanshu Huang's work include Cancer-related Molecular Pathways (57 papers), NF-κB Signaling Pathways (35 papers) and Ubiquitin and proteasome pathways (34 papers). Chuanshu Huang is often cited by papers focused on Cancer-related Molecular Pathways (57 papers), NF-κB Signaling Pathways (35 papers) and Ubiquitin and proteasome pathways (34 papers). Chuanshu Huang collaborates with scholars based in United States, China and Taiwan. Chuanshu Huang's co-authors include Zigang Dong, Weiming Ouyang, Haitian Lu, Weiya Ma, Jingxia Li, Jingxia Li, Xianglin Shi, Dongyun Zhang, Max Costa and Wei-Ya Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Chuanshu Huang

298 papers receiving 12.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation, a Key Event in Cancer Development

2006 846 citations Haitian Lu, Chuanshu Huang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuanshu Huang United States	61	7.9k	2.8k	2.5k	1.2k	1.2k	301	13.0k
Sanjay Srivastava United States	70	8.4k 1.1×	1.4k 0.5×	1.7k 0.7×	1.0k 0.8×	1.2k 1.0×	325	14.9k
Yi Sun United States	67	11.2k 1.4×	2.8k 1.0×	4.3k 1.8×	1.7k 1.4×	1.1k 0.9×	287	18.5k
Mohammad Athar United States	58	4.8k 0.6×	1.2k 0.4×	1.3k 0.5×	1.3k 1.0×	1.0k 0.9×	327	13.0k
Wen‐Chi Hou Taiwan	53	7.6k 1.0×	3.3k 1.2×	1.1k 0.5×	1.3k 1.1×	432 0.4×	219	14.1k
Thomas J. Slaga United States	61	6.8k 0.9×	3.4k 1.2×	1.8k 0.7×	786 0.6×	416 0.4×	514	13.8k
Donna D. Zhang United States	58	12.7k 1.6×	2.8k 1.0×	1.1k 0.4×	1.2k 1.0×	626 0.5×	119	16.6k
John Lunec United Kingdom	53	5.9k 0.7×	2.1k 0.7×	2.7k 1.1×	718 0.6×	616 0.5×	280	12.3k
Rolf Schulte‐Hermann Austria	57	6.1k 0.8×	2.5k 0.9×	2.5k 1.0×	852 0.7×	725 0.6×	202	12.2k
Anil K. Jaiswal United States	58	10.8k 1.4×	1.4k 0.5×	784 0.3×	1.2k 0.9×	691 0.6×	228	16.1k
Marcello Maggiolini Italy	63	5.5k 0.7×	1.9k 0.7×	2.5k 1.0×	740 0.6×	764 0.6×	206	12.0k

Countries citing papers authored by Chuanshu Huang

Since Specialization

Citations

This map shows the geographic impact of Chuanshu Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanshu Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanshu Huang more than expected).

Fields of papers citing papers by Chuanshu Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanshu Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanshu Huang. The network helps show where Chuanshu Huang may publish in the future.

Co-authorship network of co-authors of Chuanshu Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanshu Huang. A scholar is included among the top collaborators of Chuanshu Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanshu Huang. Chuanshu Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Bin, Zhiqiang Zhao, Zhenyu Xuan, et al.. (2025). mRNA-Based FRET-FLIM Imaging Platform for Quantifying Lipid Nanoparticle Endosomal Escape and Membrane Damage. Journal of the American Chemical Society. 147(34). 30907–30923. 1 indexed citations

Huang, Chuanshu, Feng Chen, Li Zhang, et al.. (2020). 99mTc Radiolabeled HA/TPGS-Based Curcumin-Loaded Nanoparticle for Breast Cancer Synergistic Theranostics: Design, in vitro and in vivo Evaluation. SHILAP Revista de lepidopterología. 2 indexed citations

So, Jae Young, Nicolas Skrypek, Howard H. Yang, et al.. (2020). Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization. Cancer Research. 80(12). 2612–2627. 40 indexed citations

Wang, Jingjing, Ning Zhang, Xiaohui Hua, et al.. (2019). p85α Inactivates MMP-2 and Suppresses Bladder Cancer Invasion by Inhibiting MMP-14 Transcription and TIMP-2 Degradation. Neoplasia. 21(9). 908–920. 11 indexed citations

Huang, Chao, Chao Huang, Xin Liao, et al.. (2019). MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion. Molecular Therapy — Nucleic Acids. 16. 51–62. 46 indexed citations

Gao, Xin, Wei Zheng, Xinyu Wen, et al.. (2019). Exploration of bladder cancer-associated methylated miRNAs by methylated DNA immunoprecipitation sequencing. SHILAP Revista de lepidopterología. 1 indexed citations

Jiang, Guosong, Chao Huang, Jingxia Li, et al.. (2018). Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells. Carcinogenesis. 39(3). 482–492. 20 indexed citations

Liao, Xin, Chao Huang, Chao Huang, et al.. (2017). Mitochondrial catalase induces cells transformation through nucleolin-dependent Cox-2 mRNA stabilization. Free Radical Biology and Medicine. 113. 478–486. 14 indexed citations

Jiang, Guosong, Chao Huang, Jiayan Gu, et al.. (2016). Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis. Cancer Prevention Research. 9(7). 567–580. 59 indexed citations

10.

Huang, Haishan, Xiaofu Pan, Honglei Jin, et al.. (2015). PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure. Clinical Cancer Research. 21(16). 3783–3793. 54 indexed citations

11.

He, Feng, Jonathan Melamed, Moon‐shong Tang, Chuanshu Huang, & Xue‐Ru Wu. (2015). Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53 -Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas. Cancer Research. 75(10). 2017–2028. 25 indexed citations

12.

Cao, Zipeng, Xueyong Li, Jingxia Li, et al.. (2013). SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage‐independent growth of cancer cells. Molecular Oncology. 8(2). 285–296. 7 indexed citations

13.

Huang, Chuanshu, et al.. (2012). Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma. Clinical and Experimental Dermatology. 37(4). 411–417. 18 indexed citations

14.

Zhou, Hong‐Hao, Weiwei Huang, Ellen Shapiro, et al.. (2012). Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies. Carcinogenesis. 33(4). 770–780. 17 indexed citations

15.

Huang, Chuanshu, Jingxia Li, & Gary D. Stoner. (2006). Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced AP-1 activation and VEGF transcription by targeting the PI-3K/Akt pathway.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

16.

Li, Jingxia, Haitian Lu, & Chuanshu Huang. (2006). NFAT3 is Required for EGF-Induced COX-2 Transcription, but Neither iNOS Transcription Nor Cell Transformation in Cl 41 Cells. Molecular and Cellular Biochemistry. 289(1-2). 73–82. 5 indexed citations

17.

Ito, Ken‐ichi, Manuel Salto‐Tellez, T. Yano, et al.. (2006). RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization (vol 65, pg 7743, 2005). Cancer Research. 66. 3345–3345. 1 indexed citations

18.

Lü, Bin, Liying Wang, Christian Stehlik, et al.. (2006). Phosphatidylinositol 3-Kinase/Akt Positively Regulates Fas (CD95)-Mediated Apoptosis in Epidermal Cl41 Cells. The Journal of Immunology. 176(11). 6785–6793. 59 indexed citations

19.

Lu, Haitian, Xianglin Shi, Max Costa, & Chuanshu Huang. (2005). Carcinogenic effect of nickel compounds. Molecular and Cellular Biochemistry. 279(1-2). 45–67. 163 indexed citations

20.

Huang, Chuanshu, et al.. (1997). Inhibition of Ultraviolet B-induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice. Journal of Biological Chemistry. 272(42). 26325–26331. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact